Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy
C. Montalban et al., Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's disease treated with chemotherapy, LEUK LYMPH, 39(5-6), 2000, pp. 563-572
The effect of molecular factors in the outcome of Hodgkin's Disease (HD) is
being currently studied. In a previous series of HD, including patients tr
eated only with radiotherapy and patients treated with chemotherapy (with o
r without radiotherapy), we found that a high proliferation index had an ad
verse influence in overall survival (OS) and in the achievement of a comple
te remission (CR). Loss of Rb expression also had an adverse prognostic inf
luence in achievement of CR, On the other hand LMP1-EBV expression had a fa
vorable influence for OS. The expression of other molecular factors, p53, b
c12 and CD15 did not show prognostic influence. In the present paper we hav
e studied the effect of these molecular variables in 110 patients, of the p
revious series who had been treated with chemotherapy. A retrospective stud
y was performed in these 110 patients with HD treated with chemotherapy (AB
VD or variants, 62%, or regimes not containing adriamycin, 38%) with or wit
hout adjutant radiotherapy, collected at the 11 centers belonging to the Sp
anish Collaborative Group for the Study of Hodgkin's Disease. The prognosti
c value of clinical variables and the expression of p53, bc12, CD15, Rb, LM
P I-EBV and proliferative fraction demonstrated with sensitive immunohistoc
hemical methods were studied. Cox's multivariate analysis was performed to
assess their influence in failure-free survival (FFS) and OS. A multivariat
e logistic regression analysis was performed for studying the effect of the
variables in the achievement of a CR.
Of the clinical variables, only advanced stage (III/IV) had a significant i
ndependent adverse influence in FFS, in OS and in the achievement of CR and
advanced age in OS. Of the molecular variables, LMP1-EBV had an independen
t and strong favorable influence in FFS, in OS and in the achievement of CR
. Rb expression had a modest favorable influence in CR. The rest of the mol
ecular variables had no independent influence on the outcome of the disease
. In conclusion these results confirm the favorable prognostic value of LMP
I-EBV expression in the subset of patients with HD treated with chemotherap
y.